世界の次世代シーケンシング(NGS)市場：プラットフォーム、バイオインフォマティクス、技術、用途...市場調査レポートについてご紹介

Table of Contents

1 Introduction (Page No. – 21)
1.1 Objectives Of The Study
1.2 Markets Covered
1.3 Stakeholders
1.4 Market Scope

2 Research Methodology (Page No. – 25)
2.1 Market Size Estimation
2.2 Market Crackdown And Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions
2.3.3.1 Key Industry Insights

3 Executive Summary (Page No. – 31)

4 Premium Insights (Page No. – 35)
4.1 Attractive Market Opportunities In The Next-Generation Sequencing (NGS) Market
4.3 Nxt Generation sequencing Market, By Product Segment
4.4 NGS Platform Market Size (Units)
4.5 NGS Market Growth Opportunities, By Geography
4.6 Life Cycle Analysis, By Geography
4.7 NGS Market In Asian Region
4.8 Company Market Share Analysis, By Geography
4.9 NGS Market, By Application

5 Market Overview (Page No. – 43)
5.1 Introduction
5.2 Evolution
5.3 Market Segmentation
5.4 Market Dynamics
5.4.1 Drivers
5.4.1.1 Cost And Speed To Drive The Growth Of NGS Technology
5.4.1.2 Substitution Of Microarray Technology By NGS To Boost Market Growth
5.4.1.3 Embracement Of NGS Technology By New Consumers To Propel The Market
5.4.1.4 Increase In Practice For New Scientific Applications To Boost Growth Of NGS Market
5.4.1.5 Research Laboratories And Academicians Promoting NGS
5.4.1.6 Global Alliances AmoNGSt Leading Research Institutes To Trigger Drug Discovery, Thus Increase The Demand Of NGS
5.4.1.7 Entry Of New Players Propelling The Growth Of The NGS Market
5.4.2 Restraints
5.4.2.1 High Reliability On Grants To Restrict Growth
5.4.2.2 Decrease In Capital Expenditure From Academic Institutes To Hinder The Sale Of Platforms
5.4.2.3 Accuracy & Standardization Concerns In Diagnostic Testing
5.4.2.4 Ethical And Legal Issues Related To Next-Generation Sequencing To Hinder The Adoption, Albeit To A Less Extent
5.4.3 Opportunities
5.4.3.1 Personalized Medicine & Biomarker Discovery Open Avenues For Investments In NGS Technology
5.4.3.2 Pre-Sequencing A High Growth Opportunity
5.4.3.3 Cloud Computing, A Prospective Service
5.4.4 Challenges
5.4.4.1 Interpretation Of Complex Data From NGS Platforms
5.4.5 Market Trend
5.4.5.1 Shift Of Focus Towards Third-Generation Sequencing
5.4.6 Burning Issues
5.4.6.1 Data Storage An Impediment To NGS Sequencing
5.4.6.2 Reduction In Cost To Sequence Human Genomes
5.4.7 Winning Imperative
5.4.7.1 Improved Collaborative Ties Between Industry And Academic & Research Institutes

6 Industry Trends (Page No. – 56)
6.1 Value Chain Analysis
6.2 Porter’s Five Forces Analysis
6.2.1 Threat From New Entrants
6.2.2 Threat From Substitutes
6.2.3 Bargaining Power Of Buyers
6.2.4 Bargaining Power Of Suppliers
6.2.5 Competitive Rivalry Among Exisiting Firms
6.3 Technological Development Road-Map
6.3.1 Sanger Sequencing
6.3.2 Massively Parallel Sequencing (Next Generation Sequencing)
6.3.3 Single Molecule Real Time (Smrt) Sequencing
6.3.4 Nanopore Sequencing
6.4 Technological Trends
6.4.1 Nanopore Sequencing Technology
6.4.1.1 Oxford Nanopore Technologies
6.4.1.2 Roche (Genia Technologies)
6.4.1.3 Electronic Biosciences
6.4.2 Sequencing By Hybridization Technology (Gnubio)
6.4.3 Genius (Gene Electronic Nano-Integrated Ultra-Sensitive) Technology (Genapsys)
6.4.4 Lightning Terminator Sequencing Technology (Lasergen)
6.4.5 Optical Nanopore Sequencing Technology (Noblegen)
6.4.6 Nanowire Biosensor Sequencing Technology (Quantumdx)

7 Global NGS Market, By Steps In Workflow (Page No. – 61)
7.1 Introduction
7.2 Pre-Sequencing Products & Services Market
7.2.1 Sample Preparation
7.2.1.1 DNA Fragmentation, End Repair, A-Tailing And Size Selection
7.2.1.2 Library Preparation
7.2.1.3 Target Enrichment
7.2.1.4 Quality Control
7.3 Sequencing Platforms Market
7.3.1 Illumina
7.3.1.1 Hiseq Series
7.3.1.2 Hiseq X Ten
7.3.1.3 Genome Analyzer Iix
7.3.1.3.1 Low Technological Advancements Will Result Into Downfall Of Ga Iix
7.3.1.4 Miseq
7.3.1.5 Nextseq500
7.3.2 Thermo Fisher Scientific (Life Technologies)
7.3.2.1 Solid Series
7.3.2.1.1 Solid Series Shows Minimal Scope For Growth
7.3.2.2 Ion Torrent Platforms
7.3.2.2.1 Ion Torrent Pgm
7.3.2.2.1.1 Currently Ion Torrent Pgm Exceeds The Unit Sales As Compared To Its Competitor Miseq
7.3.2.2.2 Ion Proton
7.3.2.2.2.1 Ion Proton Will Be One Of The Fast Growing Platforms
7.3.3 454 Roche
7.3.3.1 GS Junior Sales Stopped In 2013 And GS Flx+ Will Grow At Slow Pace Till 2016
7.3.3.2 GS Junior
7.3.3.3 GS Flx+
7.3.4 Pacific Biosciences
7.3.4.1 Pacbio Rs Ii
7.4 Sequencing Services Market
7.5 NGS Data Analysis, Storage, And Management (Bioinformatics) Market
7.5.1 Open-Source Applications Contribute 75% To The Overall NGS Bioinformatics Solutions Market
7.5.2 NGS Data Analysis, By Product
7.5.2.1 NGS Data Analysis Software & Workbenches
7.5.2.2 NGS Data Analysis Services
7.5.3 NGS Data Analysis, By Application
7.5.3.1 Whole-Genome Sequencing
7.5.3.2 Exome Sequencing
7.5.3.3 Targeted Re-Sequencing
7.5.3.4 De Novo Sequencing
7.5.3.5 RNA-Seq
7.5.3.6 Chip-Seq
7.5.3.7 Methyl-Seq
7.5.3.8 Others
7.5.4 NGS Storage, Management & Cloud Computing Solutions

8 Next Generation Sequencing Market, By Technology (Page No. – 109)
8.1 Introduction
8.2 Sequencing By Synthesis (Sbs)
8.2.1 Sbs To Be The Fastest-Growing Technology
8.3 Ion Semiconductor Sequencing
8.3.1 Ion Semiconductor Sequencing, A Fast-Growing Market
8.4 Sequencing By Ligation (Sbl)
8.4.1 Sbl Technology To Witness Negative Growth
8.5 Pyrosequencing
8.5.1 Pyrosequencing To Grow At A Negative Rate
8.6 Single Molecule Realtime Sequencing (Smrt)
8.6.1 Smrt Technology Has Limited Applications

9 Global NGS Application Market (Page No. – 117)
9.1 Introduction
9.2 Diagnostics
9.2.1 Diagnostics Market Will Grow With Addition Of Wider Applications
9.2.2 Cancer Diagnostics To Drive The Market
9.3 Drug Discovery
9.3.1 Focus On Targeted Therapy To Boost The Next Generation Sequencing Market
9.4 Biomarker Discovery
9.4.1 Biomarker Discovery Application To Grow At A High Rate
9.5 Personalized Medicine
9.5.1 Personalized Medicine Offers Huge Potential Market
9.6 Agriculture & Animal Research
9.6.1 Applications In Crop Research & Animal Biotechnology To Boost The Next Generation Sequencing Market
9.7 Other Applications (Marine Research, Research In Bio-Fuels, Forensic Medicine, Phyleogeograpic & Phylogenetic Studies)

10 Next Generation Sequencing Market, By End-User (Page No. – 126)
10.1 Introduction
10.1.1 Research Centers, Academic & Government Institutes
10.1.1.1 NGS Is A Research-Driven Market, Hence Highest Market Share
10.1.2 Hospitals & Clinics
10.1.2.1 Segment To Show Highest Growth Rate
10.1.3 Pharmaceutical & Biotechnology Companies
10.1.3.1 Targeted Therapy, Biomarker Research To Boost Segment Growth
10.1.4 Other End-Users (Npo, Agrigenomics Organizations, Consumer Genomic Companies)

11 Next Generation Sequencing Market, By Geography (Page No. – 133)
11.1 Introduction
11.2 North America
11.2.1 Government Funding To Boost The U.S. Market
11.2.2 Funds By Canadian Government Strives To Boost Next Generation Sequencing Market
11.3 Europe
11.3.1 Germany,U.K., And Belgium Are The Hubs For Scientific Research
11.3.2 Investments In Rare Disease Research Likely To Boost The NGS Market In Europe
11.3.3 Increasing Funding For Molecular Diagnostics In Europe Is Likely To Propel The Growth Of The Whole Exome Sequencing Market
11.4 Asia
11.4.1 China: Lucrative Market For NGS Products And Services Market
11.4.2 Regular Funding From The Indian Government, An Impetus To The NGS Market
11.5 Rest Of The World (Row)
11.5.1 Bioinformatics & Biotechnology Research In Latin America To Boost The Demand For NGS Instruments & Services
11.5.2 Flourishing Bio-Research Centers & Financial Support In Australia & Brazil Will Propel The Market

12 Competitive Landscape (Page No. – 162)
12.1 Overview
12.2 Market Share Analysis
12.2.1 Global NGS Platform Market
12.3 New Product Launches
12.4 Agreements And Partnerships
12.5 Mergers & Acquisitions
12.6 Expansions

13 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 172)
13.1 Introduction
13.2 454 Life Sciences Corporation (Roche Holding Ag)
13.2.1 Business Overview
13.2.2 Financials
13.2.3 Products & Services
13.2.4 Strategy
13.2.5 Recent Developments
13.3 Agilent Technologies, Inc.
13.3.1 Business Overview
13.3.2 Financials
13.3.3 Products And Services
13.3.4 Key Strategy
13.3.5 Recent Developments
13.4 Bgi (Beijing Genomics Institute)
13.4.1 Business Overview
13.4.2 Financials
13.4.3 Products & Services
13.4.4 Key Strategy
13.4.5 Recent Developments
13.5 Biomatters, Ltd.
13.5.1 Business Overview
13.5.2 Financials
13.5.3 Products & Services
13.5.4 Key Strategy
13.5.5 Recent Developments
13.6 Clc Bio (Acquired By Qiagen)
13.6.1 Business Overview
13.6.2 Financials
13.6.3 Products & Services
13.6.4 Key Strategy
13.6.5 Recent Developments
13.7 Dnastar, Inc.
13.7.1 Business Overview
13.7.2 Financials
13.7.3 Products & Services
13.7.4 Key Strategy
13.7.5 Recent Developments
13.8 Gatc Biotech Ag
13.8.1 Business Overview
13.8.2 Financials
13.8.3 Products & Services
13.8.4 Key Strategy
13.8.5 Recent Developments
13.9 Genomatix Software Gmbh
13.9.1 Business Overview
13.9.2 Financials
13.9.3 Products & Services
13.9.4 Key Strategy
13.9.5 Recent Developments
13.1 Illumina, Inc.
13.10.1 Business Overview
13.10.2 Financials
13.10.3 Products & Services
13.10.4 Key Strategy
13.10.5 Recent Developments
13.10.6 Swot
13.10.7 Mnm View
13.11 Knome, Inc.
13.11.1 Business Overview
13.11.2 Financials
13.11.3 Products & Services
13.11.4 Key Strategy
13.11.5 Recent Developments
13.12 Life Technologies Corporation (Thermo Fisher Scientific)
13.12.1 Business Overview
13.12.2 Financials
13.12.3 Products & Services
13.12.4 Key Strategy
13.12.5 Recent Developments
13.12.6 Swot
13.12.7 Mnm View
13.13 Macrogen, Inc.
13.13.1 Business Overview
13.13.2 Financials
13.13.3 Products & Services
13.13.4 Key Strategy
13.13.5 Recent Developments
13.14 Oxford Nanopore Technologies, Ltd.
13.14.1 Overview
13.14.2 Financials
13.14.3 Products & Services
13.14.4 Key Strategy
13.14.5 Recent Developments
13.15 Pacific Biosciences
13.15.1 Business Overview
13.15.2 Financials
13.15.3 Products & Services
13.15.4 Key Strategy
13.15.5 Recent Developments
13.15.6 Swot
13.15.7 Mnm View
13.16 Partek Incorporated
13.16.1 Business Overview
13.16.2 Financials
13.16.3 Products & Services
13.16.4 Key Strategy
13.16.5 Recent Developments
13.17 Perkin Elmer, Inc.
13.17.1 Business Overview
13.17.2 Financials
13.17.3 Products & Services
13.17.4 Key Strategy
13.17.5 Recent Developments
13.18 Qiagen N.V.
13.18.1 Business Overview
13.18.2 Financials
13.18.3 Products & Services
13.18.4 Key Strategy
13.18.5 Recent Developments
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

14 Appendix (Page No. – 233)
14.1 Insights Of Industry Experts
14.2 Discussion Guide
14.3 Available Customizations
14.4 Related Reports
14.5 Introducing Rt: Real Time Market Intelligence